Did you know there’s even more we can do to promote your episode? Find out more…
Episode 212
The master-builder now on a cell therapy crusade
Jason C. Foster
/ Ori Biotech
Jason C. Foster shares his journey from big pharma to leading Ori Biotech and tackling cell and gene therapy manufacturing.
Episode 211
From astrophysicist to biopharma industry leader
Ben Locwin
/ Black Diamond Networks
Ben Locwin, Chief Scientist at Black Diamond Networks, joins Molecule to Market to share his journey from astrophysics to biotech and leading CDMO insights.
Episode 210
From Big Pharma to Snapdragon
Matthew Bio
/ Cambrex & Snapdragon Chemistry
Matthew Bio, CSO of Cambrex & President of Snapdragon Chemistry, shares insights on pharma outsourcing, continuous manufacturing, and leadership.
Episode 209
The LATAM CRO Queen
Sara Tylosky
/ Farmacon Global
Sara Tylosky, CEO at Farmacon Global, joins us to discuss rare disease trials, patient access, and LATAM’s growing pharma role.
Episode 208
The pulse of Big Pharma CEOs
Ray Pressburger
/ Accenture Strategy
Ray Pressburger, Senior Managing Director at Accenture, joins Raman to explore the top five themes shaping the strategies of big pharma CEOs.
Episode 207
How to plan for life sciences events in 2025
Luke Bilton
/ PharmaSource | CDMO Live | Life Sciences Networks
Luke Bilton, Co-Founder of Life Science Networks, talks about the crucial role of events in pharma outsourcing in his recent chat with Raman.
Episode 206
Biopharma Global Supply veteran
Robert Bottome
/
Retired industry veteran Robert Bottome shares his unique insights on pharma logistics and supply chains after years of impactful work.
Episode 205
Meet the healthcare futurist
Imran Kausar
/ DeepHealth Consulting
Imran Kausar, Founder of DeepHealth Consulting, joins the podcast to discuss gene therapies, their pricing, and the value they bring to patients.
Episode 204
The dynamic duo driving global growth
Myonex
/ James Lovett & Mike Cohen
James Lovett & Mike Cohen from Myonex join the podcast to share insights on driving success in clinical trials and fueling sustainable organic growth.
Episode 203
Biopharma Insights: Live from J.P. Morgan
Dean McAlister
/ Inizio Biotech
Dean McAlister, EVP at Inizio Biotech, joins the podcast live from J.P. Morgan 2025 to share insights on the life sciences sector outlook.
